Aurora Cannabis Sees Unusually High Options Volume (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) saw unusually large options trading on Wednesday. Stock investors acquired 14,617 call options on the stock. This represents an increase of approximately 230% compared to the average volume of 4,428 call options.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Virtu Financial LLC acquired a new stake in Aurora Cannabis during the 1st quarter worth $727,000. TD Asset Management Inc acquired a new stake in shares of Aurora Cannabis during the second quarter worth about $255,000. Headlands Technologies LLC purchased a new stake in shares of Aurora Cannabis in the 1st quarter valued at about $166,000. Mackenzie Financial Corp purchased a new stake in shares of Aurora Cannabis in the 2nd quarter valued at about $113,000. Finally, Concurrent Investment Advisors LLC acquired a new stake in shares of Aurora Cannabis in the 1st quarter valued at about $90,000. 47.63% of the stock is owned by institutional investors and hedge funds.

Aurora Cannabis Stock Performance

Shares of ACB remained flat at $6.10 during midday trading on Wednesday. The stock had a trading volume of 152,338 shares, compared to its average volume of 3,176,269. Aurora Cannabis has a fifty-two week low of $2.84 and a fifty-two week high of $9.35. The firm has a market capitalization of $332.73 million, a price-to-earnings ratio of -4.36 and a beta of 1.86. The company has a quick ratio of 2.03, a current ratio of 3.76 and a debt-to-equity ratio of 0.08. The company has a 50-day moving average price of $5.85 and a 200-day moving average price of $6.05.

Aurora Cannabis (NASDAQ:ACB) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.24. The company had revenue of $67.27 million for the quarter, compared to the consensus estimate of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. Equities analysts predict that Aurora Cannabis will post -0.37 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.